Advertisement

Topics

Otsuka Maryland Research Institute (OMRI) Company Profile

15:32 EST 22nd November 2017 | BioPortfolio

Otsuka Maryland Research Institute (OMRI) is a leader in the research and clinical development of healthcare products, and is a cornerstone of the global development of Otsuka Pharmaceuticals Company, Inc.

Location

2440 Research Blvd
Rockville
MD
20850
United States of America

Contact

Phone: (301) 990-0030
Fax: (301) 212-8647
Email: debrak@otsuka.com


News Articles [1586 Associated News Articles listed on BioPortfolio]

Bipolar I disorder drug from Otsuka, Lundbeck gets FDA nod

The once-monthly, extended-release injectable Abilify Maintena, or aripiprazole, from Otsuka Pharmaceutical and H.  -More- 

Mylan partners with Otsuka to commercialize tuberculosis med delamanid in high-burden countries

Subsidiaries of Mylan N.V. and Otsuka Pharmaceutical Co. ink an agreement to commercialize delamanid, branded as Deltyba by Otsuka, for the treatment of adults with pulmonary multidrug-resistant tuber...

Otsuka Holdings' medtech business to be transferred to medical device unit

Otsuka Holdings said it intends to move its medical device business to Otsuka Medical Devices, its wholly owned unit, effecti -More- 

Maryland DBED: Will this US State be the Next Silicon Valley?

In this interview Fintan Walton speaks with Lawrence Mahan, Senior Strategy Advisor for Biosciences for the state of Maryland, and Richard Zakour, Executive Director of MdBio, at the recent BioEurope ...

UMD partners with Fraunhofer, Signature Science on DNA screening technologies

(University of Maryland) Computational biologists in the University of Maryland Institute for Advanced Computer Studies (UMIACS) are collaborating with other experts to develop new approaches and tool...

FDA Approves Pill With Sensor Abilify MyCite; Otsuka Stock Up

Schizophrenia drug Abilify MyCite becomes the first drug approved in the U.S. with a sensor that digitally tracks if patients have ingested their medication. The U.S. Food and Drug Administration on M...

University of Maryland team wins National Eye Institute Retina Organoid Challenge

A team from the University of Maryland, Baltimore County, won the National Eye Institute Retina Organoid Challenge with its proposal to create a living model of the human retina, according to an NEI p...

Otsuka Pharma And Lundbeck Announce Initiation Of Two Phase III Trials Of Brexpiprazole In Patients With Bipolar I Disorder

TOKYO & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck announce that patient enrollment has been initiated in two global Phase 3 clinical trials to...

PubMed Articles [1303 Associated PubMed Articles listed on BioPortfolio]

The Pathway to a Universal Influenza Vaccine.

Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal,...

Letter--The Authors Respond.

None of the authors of this study are involved in financial or personal relationships with agencies, institutions, or organizations that inappropriately influenced the statistical analysis plan or int...

A History of the Western Institute of Nursing and Its Communicating Nursing Research Conferences.

The Western Institute of Nursing (WIN) celebrated its 60th anniversary and the 50th Annual Communicating Nursing Research Conference in April 2017.

Maryland Action Coalition: Academic Progression Takes Several Pathways.

The purpose of this article is to provide an overview of the Maryland Action Coalition academic progression activities.

Cell scientist to watch - Paul Timpson.

Paul Timpson received his bachelor's degree from the University of Strathclyde, UK and completed his PhD under the supervision of Margaret Frame at the Beatson Institute for Cancer Research and the Un...

Clinical Trials [1515 Associated Clinical Trials listed on BioPortfolio]

Screening Protocol for Research Participants

The Screening Protocol is a system devised to evaluate potential research participants for National Institute on Drug Abuse/Maryland Psychiatric Research Center (NIDA/MPRC) studies.

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Schizophrenia and the Gut Microbiome

In a sample of 20 inpatients with a DSM-IV-TR/DSM 5 diagnosis of schizophrenia or schizoaffective disorder, investigators propose to conduct a prospective, 2 week observational trial to co...

Evaluation and Treatment of People With Eye Diseases

This study will evaluate and provide standard treatments for people with various eye conditions. It will provide a resource for enrollment into new research protocols throughout the Eye In...

Screening Protocol for the Evaluation of Research Participants at the Maryland Psychiatric Research Center (MPRC)

Background: - The National Institute of Drug Abuse (NIDA) is interested in developing a pool of potential research participants who may be eligible for research studies on drug abuse and ...

Companies [2451 Associated Companies listed on BioPortfolio]

Otsuka Maryland Research Institute (OMRI)

Otsuka Maryland Research Institute (OMRI) is a leader in the research and clinical development of healthcare products, and is a cornerstone of the global development of Otsuka Pharmaceuticals Company,...

Otsuka America Pharmaceutical, Inc.

Otsuka America Pharmaceutical, Inc. (OAPI) is a successful, innovative, fast-growing healthcare company that commercializes Otsuka-discovered and other product opportunities in North America, with a s...

Institute of Human Virology (IHV) at the University of Maryland School of Medicine

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an in...

Institute of Human Virology of The University of Maryland School of Medicine

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the Univer...

Otsuka Pharmaceutical Co., Ltd./H. Lundbeck A/S

Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: “Otsuka – people creating new products for better health worldwide.” Otsuka rese...

More Information about "Otsuka Maryland Research Institute (OMRI)" on BioPortfolio

We have published hundreds of Otsuka Maryland Research Institute (OMRI) news stories on BioPortfolio along with dozens of Otsuka Maryland Research Institute (OMRI) Clinical Trials and PubMed Articles about Otsuka Maryland Research Institute (OMRI) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Otsuka Maryland Research Institute (OMRI) Companies in our database. You can also find out about relevant Otsuka Maryland Research Institute (OMRI) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record